News
Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177 Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine MIRD Pamphlet No. 28, Part ...
Journal of Nuclear Medicine May 2025, jnumed.125.269746; DOI: https://doi.org/10.2967/jnumed.125.269746 ...
Journal of Nuclear Medicine April 2025, jnumed.124.268980; DOI: https://doi.org/10.2967/jnumed.124.268980 ...
Journal of Nuclear Medicine April 2025, jnumed.124.268706; DOI: https://doi.org/10.2967/jnumed.124.268706 ...
Journal of Nuclear Medicine March 2025, jnumed.124.268621; DOI: https://doi.org/10.2967/jnumed.124.268621 ...
Journal of Nuclear Medicine March 2025, jnumed.124.268175; DOI: https://doi.org/10.2967/jnumed.124.268175 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...
Journal of Nuclear Medicine March 2025, jnumed.124.268700; DOI: https://doi.org/10.2967/jnumed.124.268700 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269005; DOI: https://doi.org/10.2967/jnumed.124.269005 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268496; DOI: https://doi.org/10.2967/jnumed.124.268496 This paper aims to develop and evaluate the potential of ...
Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268832; DOI: https://doi.org/10.2967/jnumed.124.268832 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results